Related Experiment Video
Updated: Jul 17, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Acute and sub-acute ocular manifestations in pediatric patients with COVID-19: A systematic review
1Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Insights
Ocular manifestations are uncommon in acute COVID-19 but frequent in MIS-C. Conjunctivitis, often non-purulent, is the primary sign in pediatric MIS-C, requiring vigilant detection by healthcare providers.
Area of Science:
- Ophthalmology
- Pediatrics
- Infectious Diseases
Background:
- The COVID-19 pandemic presents significant health challenges.
- Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of COVID-19.
- Ocular manifestations can be an early indicator of MIS-C, necessitating prompt diagnosis and treatment.
Purpose of the Study:
- To systematically review and summarize acute and sub-acute ocular manifestations in pediatric patients with laboratory-confirmed COVID-19.
- To identify the prevalence and types of ocular symptoms associated with COVID-19 and MIS-C in children.
Main Methods:
- Systematic review of online primary studies published between January 1, 2019, and November 18, 2020.
- Searched PubMed/MEDLINE using comprehensive ophthalmologic and COVID-19-related terms.
- Included studies with no language restriction; eligibility and quality assessed by two independent reviewers.
Main Results:
- Of 463 pediatric patients with acute COVID-19, 15.5% exhibited acute ocular manifestations, including rare cases of retinal vein occlusion and photophobia with meningoencephalitis.
- Among 895 pediatric patients with MIS-C, 52.4% had ocular manifestations, predominantly non-purulent conjunctivitis.
Conclusions:
- Ocular symptoms are present in less than one-fifth of pediatric COVID-19 cases.
- Non-purulent conjunctivitis is the sole ocular finding in half of MIS-C patients and may be easily overlooked.
- Healthcare providers must maintain vigilance for early detection of MIS-C in pediatric patients during the COVID-19 pandemic.
Background:
The coronavirus disease 2019 (COVID-19) pandemic has been the most challenging health problem in the last 2 years. Post-COVID-19 multisystem inflammatory syndrome of children (MIS-C) is a severe post-COVID-19 complication in pediatric patients. Ocular manifestations may be the first presentation of MIS-C, wherein prompt treatment may improve outcomes. In this systematic review, we aimed to summarize the acute and sub-acute ocular manifestations in pediatric patients with laboratory-confirmed COVID-19.
Methods:
We included all online primary studies, with no language restriction and published between January 1, 2019 and November 18, 2020, reporting any acute or sub-acute ocular manifestations in children with laboratory-confirmed COVID-19. PubMed/MEDLINE was searched using the following MeSH and Emtree terms: "eye," "ophthalmologic," "ocular," "vision," "conjunctivitis," "severe acute respiratory syndrome coronavirus 2," "SARS-CoV-2," "corona," "2019-nCoV," "COVID19," and "COVID." The eligibility and quality of the selected records were assessed by two independent reviewers as per the Cochrane Handbook for Systematic Review.
Results:
A total of 1,192 records were identified electronically. Seven papers were extracted from the reference lists of the eligible records. Thirty-six papers met the inclusion criteria and were categorized into two subgroups according to acute or sub-acute presentation of ocular manifestations. Among 463 pediatric patients with COVID-19, 72 (15.5%) had acute ocular manifestations. There was one patient with central retinal vein occlusion and another with photophobia and diplopia associated with meningoencephalitis. Among 895 pediatric patients with post-COVID-19 MIS-C, 469 (52.4%) had ocular manifestations, which only included non-purulent conjunctivitis.
Conclusions:
Ocular manifestations have been reported in less than one-fifth of pediatric patients with acute COVID-19. Furthermore, conjunctivitis was the only ocular manifestation reported in half of the patients with MIS-C, and it may be missed easily due to its non-purulent nature. During the COVID-19 pandemic, pediatricians and health workers must remain vigilant for early detection of signs of this potentially fatal post-COVID-19 inflammatory syndrome.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Acute Kidney Injury III: Clinical Manifestations
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Accessory Structures of the Eye
Photoreceptors and Visual Pathways

